Menu Back toCardioVascular Safety: The New Paradigm - Proarrhythmic Assessment of New Drugs without the Thorough QT Study

CardioVascular Safety: The New Paradigm - Proarrhythmic Assessment of New Drugs without the Thorough QT Study